The UK has become a "relatively small market" since leaving the European Union, the boss of Eli Lilly said in an interview.
The ‘donut hole’ gap in drug coverage will disappear under changes to the government’s health insurance for seniors.
The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies are pursuing other approaches that could be even more effective or ...
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...